The 2018 Request for Application (RFA) is now closed.
Continuation of Funding
(for existing grantees only)
Currently funded NETRF investigators with projects that are finishing during 2018 have the option to apply for continuation of funding. Investigators interested in applying under this category should get in touch with the Director of Research.
Cell Line Prize
We are currently not accepting applications for the cell line prize.
Please visit our site in 2018 for an update.
The lack of well-validated and widely accepted cell lines derived from intestinal carcinoid and pancreatic neuroendocrine tumors (PNET) is a significant barrier for research and development of new therapies. The Neuroendocrine Tumor Research Foundation therefore wishes to stimulate a concerted effort to create a “collection” of well-characterized cell lines that faithfully replicate tumor characteristics and genetics. The Foundation has partnered with the Rare Cancer Research Foundation (RCRF), a foundation dedicated to curing rare cancers through strategic investments and innovative collaborations, and the American Type Culture Collection (ATCC), the world’s largest non-profit cell line repository, to establish a Neuroendocrine Tumor Cell Line collection in their catalog. This challenge requires written documentation, detailed description of each cell line, and sample delivery.
